Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Lack of data drives uncertainty in PCB health risk assessments

Abstract

Health risk assessments generally involve many extrapolations: for example, from animals to humans or from high doses to lower doses. Health risk assessments for PCBs involve all the usual uncertainties, plus additional uncertainties due to the nature of PCBs as a dynamic, complex mixture. Environmental processes alter PCB mixtures after release into the environment, so that people are exposed to mixtures that might not resemble the mixtures where there are toxicity data. This paper discusses the evolution of understanding in assessments of the cancer and noncancer effects of PCBs. It identifies where a lack of data in the past contributed to significant uncertainty and where new data subsequently altered the prevailing understanding of the toxicity of PCB mixtures, either qualitatively or quantitatively. Finally, the paper identifies some uncertainties remaining for current PCB health assessments, particularly those that result from a lack of data on exposure through nursing or on effects from inhalation of PCBs.

This is a preview of subscription content, log in to check access.

References

  1. Ahlborg UG, Becking GC, Birnbaum LS, Brouwer A, Derks HJGM, Feeley M, Golor G, Hanberg A, Larsen JC, Liem AK et al (1994) Toxic equivalency factors for dioxin-like PCBs. Chemosphere 28(6):1049–1067

  2. Al-Salman F, Plant N (2012) Non-coplanar polychlorinated biphenyls (PCBs) are direct agonists for the human pregnane-X receptor and constitutive androstane receptor, and activate target gene expression in a tissue-specific manner. Toxicol Appl Pharmacol 263(1):7–13

  3. ATSDR (2000) Toxicological profile for polychlorinated biphenyls (PCBs). http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=142&tid=26

  4. Brunner MJ, Sullivan TM, Singer AW, Ryan MJ, Toft JD II, Menton RS, Graves SW, Peters AC (1996) An assessment of the chronic toxicity and oncogenicity of Aroclor-1016, Aroclor-1242, Aroclor-1254, and Aroclor-1260 administered in diet to rats. Battelle Study No SC920192. Battelle, Columbus

  5. California Environmental Protection Agency (2007) Public health goal for water soluble polychlorinated biphenyls expected to be found in drinking water. http://www.oehha.ca.gov/water/phg/pdf/PCBphg10052007.pdf

  6. Cogliano VJ (1998) Assessing the cancer risk from environmental PCBs. Environ Health Perspect 106(6):317–323

  7. Guo J, Capozzi SL, Kraeutler TM, Rodenburg LA (2014) Global distribution and local impacts of inadvertently generated polychlorinated biphenyls in pigments. Environ Sci Technol 48(15):8573–8580

  8. Hori S, Obana H, Kashimoto T, Otake T, Nishimura H, Ikegami N, Kunita N, Uda H (1982) Effect of polychlorinated biphenyls and polychlorinated quaterphenyls in Cynomolgus monkey (Macaca fascicularis). Toxicology 24(2):123–139

  9. Hu D, Martinez A, Hornbuckle KC (2008) Discovery of non-aroclor PCB (3,3′-dichlorobiphenyl) in Chicago air. Environ Sci Technol 42(21):7873–7877

  10. IARC (1978) IARC Monographs on the evaluation of carcinogenic risks to humans, volume 18, polychlorinated biphenyls and polybrominated biphenyls. http://monographs.iarc.fr/ENG/Monographs/vol1-42/mono18.pdf

  11. IARC (1987) IARC Monographs on the evaluation of carcinogenic risks to humans, supplement 7, overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. http://monographs.iarc.fr/ENG/Monographs/suppl7/index.php

  12. IARC (2015) IARC Monographs on the evaluation of carcinogenic risks to humans, volume 107, polychlorinated biphenyls and polybrominated biphenyls. http://monographs.iarc.fr/ENG/Monographs/vol107/index.php

  13. Ito N, Nagasaki H, Arai M, Makiura S, Sugihara S, Hirao K (1973) Histopathologic studies on liver tumorigenesis induced in mice by technical polychlorinated biphenyls and its promoting effect on liver tumors induced by benzene hexachloride. J Natl Cancer Inst 51(5):1637–1646

  14. Ito N, Nagasaki H, Makiura S, Arai M (1974) Histopathological studies on liver tumorigenesis in rats treated with polychlorinated biphenyls. Gann 65:545–549

  15. Jansen HT, Cooke PS, Porcelli J, Liu TC, Hansen LG (1993) Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol 7(3):237–248

  16. Kimbrough RD, Squire RA, Linder RE, Strandberg JD, Montali RJ, Burse VW (1975) Induction of liver tumors in Sherman strain female rats by polychlorinated biphenyl Aroclor 1260. J Natl Cancer Inst 55:1453–1459

  17. Kodavanti PRS, Kannan N, Yamashita N, Derr-Yellin EC, Ward TR, Burgin DE, Tilson HA, Birnbaum LS (2001) Differential effects of two lots of Aroclor 1254: congener-specific analysis and neurochemical end points. Environ Health Perspect 109(11):1153–1161

  18. Lauby-Secretan B, Loomis D, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K, on behalf of the International Agency for Research on Cancer Monograph Working Group (2013) Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet Oncol 14(4):287–288

  19. Lehmann GM, Christensen K, Maddaloni M, Phillips LJ (2015) Evaluating health risks from inhaled polychlorinated biphenyls: research needs for addressing uncertainty. Environ Health Perspect 123(2):109–113

  20. Mayes BA, Mc Connell EE, Neal BH, Brunner MJ, Hamilton SB, Peters AC, Ryan MJ, Toft JD, Singer AW, Brown JF Jr, Menton RG, Moore JA Jr (1998) Comparative carcinogenicity in Sprague-Dawley rats of the polychlorinated biphenyl mixtures Aroclors 1016, 1242, 1254, and 1260. Toxicol Sci 41(1):62–76

  21. Moore JA, Hardisty JF, Banas DA, Smith MA (1994) A comparison of liver tumor diagnoses from seven PCB studies in rats. Regul Toxicol Pharmacol 20:362–370

  22. NCI (1978) Bioassay of Aroclor 1254 for possible carcinogenicity. Carcinogenesis Technical Report Series 38. http://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr038.pdf#search=tr-38

  23. Norback DH, Weltman RH (1985) Polychlorinated biphenyl induction of hepatocellular carcinoma in the Sprague-Dawley rat. Environ Health Perspect 60:97–105

  24. Rodenburg LA, Guo J, Du S, Cavallo GJ (2010) Evidence for unique and ubiquitous environmental sources of 3,3′-dichlorobiphenyl (PCB 11). Environ Sci Technol 44(8):2816–2821

  25. Safe S (1994) Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 24(2):87–149

  26. Schaeffer E, Greim H, Goessner W (1984) Pathology of chronic polychlorinated biphenyl (PCB) feeding in rats. Toxicol Appl Pharmacol 75:278–288

  27. Silberhorn EM, Glauert HP, Robertson LW (1990) Carcinogenicity of polyhalogenated biphenyls: PCBs and PBBs. Crit Rev Toxicol 20(6):439–496

  28. Silkworth JB, Grabstein EM (1982) Polychlorinated biphenyl immunotoxicity: dependence on isomer planarity and the Ah gene complex. Toxicol Appl Pharmacol 65(1):109–115

  29. Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier C, Rusyn I, DeMarini DM, Caldwell JC, Kavlock R, Lambert P, Hecht SS, Bucher JR, Stewart BW, Baan R, Cogliano V, Straif K (2015) Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect, in press

  30. U.S. EPA (1992) Aroclor 1016: reference dose for chronic oral exposure (RfD). http://www.epa.gov/iris/subst/0462.htm

  31. U.S. EPA (1994a) Aroclor 1254: reference dose for chronic oral exposure (RfD). http://www.epa.gov/iris/subst/0389.htm

  32. U.S. EPA (1994b) Aroclor 1248: reference dose for chronic oral exposure (RfD). http://www.epa.gov/iris/subst/0649.htm

  33. U.S. EPA (1996) PCB: cancer dose-response assessment and application to environmental mixtures. EPA/600/P-96/001F. http://cfpub.epa.gov/ncea/iris_drafts/recordisplay.cfm?deid=12486

  34. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws L, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tyskind M, Walker N, Peterson RE (2006) The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223–241

Download references

Disclaimer

This manuscript does not necessarily represent the views or policies of the U.S. Environmental Protection Agency. The mention of commercial products or trade names does not constitute endorsement or recommendation for use.

Author information

Correspondence to Vincent James Cogliano.

Additional information

Responsible editor: Markus Hecker

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cogliano, V.J. Lack of data drives uncertainty in PCB health risk assessments. Environ Sci Pollut Res 23, 2212–2219 (2016). https://doi.org/10.1007/s11356-015-5157-4

Download citation

Keywords

  • PCBs
  • Hazard classification
  • Toxicity value
  • Uncertainty
  • Cancer
  • Partitioning
  • Transformation
  • Bioaccumulation